The homo sapiens KRAS oncogene (GTPase (KRAS), transcript variant X2, mRNA—Accession number: XM_011520653), mutations of which guide treatment decisions in colorectal cancer (CRC), was used as a model gene. This evidence concerns the gene KRAS and colorectal cancer.